Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

Bristol Myers BMY recently secured a meaningful label expansion for Sotyktu, with the FDA approving the drug for adults with ...

Patients with axial spondyloarthritis and psoriatic arthritis face an elevated risk for all-cause mortality compared with the ...

Oral TYK2 inhibitor deucravacitinib receives FDA approval for active psoriatic arthritis based on significantly improved ...

Psoriatic arthritis is a condition that brings many challenges, both for patients and for doctors. One of the most important ones is that you need to have patience with this disease. There's not a ...

Psoriatic arthritis is an autoimmune disease that causes inflammation of the skin, joints, tendons, and nails. It can cause pain, swelling, stiffness, and reduced range of motion. Treatment of ...

In phase 3 clinical trials, tildrakizumab treatment was associated with significantly higher ACR20 response rates at week 24 compared with placebo.

Ilumya has secured marketing authorisations from more than 55 health authorities worldwide.

P soriatic arthritis is an autoimmune condition where the body’s immune system mistakenly attacks joints and connective tissue. This leads to a cascade of inflammation that causes painful symptoms, ...

Psoriatic arthritis happens when your immune system mistakenly attacks healthy cells in your body. (About 1.5 million 2 people in America have psoriatic arthritis.) If you are trying to determine ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the ...

Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis—a condition that features red patches of skin topped with silvery scales. Most people develop psoriasis first and ...